Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080293652A1
SERIAL NO

10598356

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of p53 gene therapy to treat recurrent cancers in combination with a radio- or chemotherapy. Patients with recurring cancers are treated with a p53 expression construct followed by subsequent radio- or chemotherapy treatment. Viral and non-viral delivery systems, as well as various radio- and chemotherapy regimens are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTROGEN THERAPEUTICS INC301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Menander, Kerstin Bellaire, TX 7 71
Sobol, Robert Rancho Sante Fe, CA 6 68

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation